Selected research
Industry Research
Coagulation Factor VIIa Industry Research Report 2026
Market perspective
The global Coagulation Factor VIIa market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Coagulation Factor VIIa is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Coagulation Factor VIIa is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Coagulation Factor VIIa is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Coagulation Factor VIIa include Novo Nordisk, LFB SA HEMA Biologics, GENERIUM and AryoGen Pharmed, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Coagulation Factor VIIa market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Coagulation Factor VIIa Market by Company
Novo Nordisk
LFB SA HEMA Biologics
GENERIUM
AryoGen Pharmed
Coagulation Factor VIIa Segment by Type
Prefilled Syringe
Vial
Coagulation Factor VIIa Segment by Application
Congenital Hemophilia
Acquired Hemophilia
Other
Coagulation Factor VIIa Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor VIIa market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor VIIa and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor VIIa.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Coagulation Factor VIIa manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Coagulation Factor VIIa by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Coagulation Factor VIIa in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prefilled Syringe
- Vial
Applications
- Congenital Hemophilia
- Acquired Hemophilia
- Other
Companies covered
- Novo Nordisk
- LFB SA HEMA Biologics
- GENERIUM
- AryoGen Pharmed
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Coagulation Factor VIIa Market Size (2021-2032)
- 2.2.2 Global Coagulation Factor VIIa Sales (2021-2032)
- 2.2.3 Global Coagulation Factor VIIa Market Average Price (2021-2032)
- 2.3 Coagulation Factor VIIa by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Prefilled Syringe
- 2.3.3 Vial
- 2.4 Coagulation Factor VIIa by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Congenital Hemophilia
- 2.4.3 Acquired Hemophilia
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Coagulation Factor VIIa Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Coagulation Factor VIIa Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Coagulation Factor VIIa Revenue of Manufacturers (2021-2026)
- 3.4 Global Coagulation Factor VIIa Average Price by Manufacturers (2021-2026)
- 3.5 Global Coagulation Factor VIIa Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Coagulation Factor VIIa, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Coagulation Factor VIIa, Product Type & Application
- 3.8 Global Manufacturers of Coagulation Factor VIIa, Established Date
- 3.9 Global Coagulation Factor VIIa Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novo Nordisk
- 4.1.1 Novo Nordisk Company Information
- 4.1.2 Novo Nordisk Business Overview
- 4.1.3 Novo Nordisk Coagulation Factor VIIa Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novo Nordisk Coagulation Factor VIIa Product Portfolio
- 4.1.5 Novo Nordisk Recent Developments
- 4.2 LFB SA HEMA Biologics
- 4.2.1 LFB SA HEMA Biologics Company Information
- 4.2.2 LFB SA HEMA Biologics Business Overview
- 4.2.3 LFB SA HEMA Biologics Coagulation Factor VIIa Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 LFB SA HEMA Biologics Coagulation Factor VIIa Product Portfolio
- 4.2.5 LFB SA HEMA Biologics Recent Developments
- 4.3 GENERIUM
- 4.3.1 GENERIUM Company Information
- 4.3.2 GENERIUM Business Overview
- 4.3.3 GENERIUM Coagulation Factor VIIa Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GENERIUM Coagulation Factor VIIa Product Portfolio
- 4.3.5 GENERIUM Recent Developments
- 4.4 AryoGen Pharmed
- 4.4.1 AryoGen Pharmed Company Information
- 4.4.2 AryoGen Pharmed Business Overview
- 4.4.3 AryoGen Pharmed Coagulation Factor VIIa Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AryoGen Pharmed Coagulation Factor VIIa Product Portfolio
- 4.4.5 AryoGen Pharmed Recent Developments
5 Global Coagulation Factor VIIa Market Scenario by Region
- 5.1 Global Coagulation Factor VIIa Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Coagulation Factor VIIa Sales by Region: 2021-2032
- 5.2.1 Global Coagulation Factor VIIa Sales by Region: 2021-2026
- 5.2.2 Global Coagulation Factor VIIa Sales by Region: 2027-2032
- 5.3 Global Coagulation Factor VIIa Revenue by Region: 2021-2032
- 5.3.1 Global Coagulation Factor VIIa Revenue by Region: 2021-2026
- 5.3.2 Global Coagulation Factor VIIa Revenue by Region: 2027-2032
- 5.4 North America Coagulation Factor VIIa Market Facts & Figures by Country
- 5.4.1 North America Coagulation Factor VIIa Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Coagulation Factor VIIa Sales by Country (2021-2032)
- 5.4.3 North America Coagulation Factor VIIa Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Coagulation Factor VIIa Market Facts & Figures by Country
- 5.5.1 Europe Coagulation Factor VIIa Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Coagulation Factor VIIa Sales by Country (2021-2032)
- 5.5.3 Europe Coagulation Factor VIIa Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Coagulation Factor VIIa Market Facts & Figures by Country
- 5.6.1 Asia Pacific Coagulation Factor VIIa Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Coagulation Factor VIIa Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Coagulation Factor VIIa Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Coagulation Factor VIIa Market Facts & Figures by Country
- 5.7.1 South America Coagulation Factor VIIa Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Coagulation Factor VIIa Sales by Country (2021-2032)
- 5.7.3 South America Coagulation Factor VIIa Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Coagulation Factor VIIa Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Coagulation Factor VIIa Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Coagulation Factor VIIa Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Coagulation Factor VIIa Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Coagulation Factor VIIa Sales by Type (2021-2032)
- 6.1.1 Global Coagulation Factor VIIa Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Coagulation Factor VIIa Sales Market Share by Type (2021-2032)
- 6.2 Global Coagulation Factor VIIa Revenue by Type (2021-2032)
- 6.2.1 Global Coagulation Factor VIIa Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Coagulation Factor VIIa Revenue Market Share by Type (2021-2032)
- 6.3 Global Coagulation Factor VIIa Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Coagulation Factor VIIa Sales by Application (2021-2032)
- 7.1.1 Global Coagulation Factor VIIa Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Coagulation Factor VIIa Sales Market Share by Application (2021-2032)
- 7.2 Global Coagulation Factor VIIa Revenue by Application (2021-2032)
- 7.2.1 Global Coagulation Factor VIIa Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Coagulation Factor VIIa Revenue Market Share by Application (2021-2032)
- 7.3 Global Coagulation Factor VIIa Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Coagulation Factor VIIa Value Chain Analysis
- 8.1.1 Coagulation Factor VIIa Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Coagulation Factor VIIa Production Mode & Process
- 8.2 Coagulation Factor VIIa Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Coagulation Factor VIIa Distributors
- 8.2.3 Coagulation Factor VIIa Customers
9 Global Coagulation Factor VIIa Analyzing Market Dynamics
- 9.1 Coagulation Factor VIIa Industry Trends
- 9.2 Coagulation Factor VIIa Industry Drivers
- 9.3 Coagulation Factor VIIa Industry Opportunities and Challenges
- 9.4 Coagulation Factor VIIa Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst